scPharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-J. Luther King, Jr.(5.8%),Luther King Capital Management Corporation(5.5%)
scPharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Lundbeckfond Invest A/S (“Lundbeckfond”)(5.7%),Lene Skole (“Skole”)(5.7%)
scPharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Laurence W. Lytton(5.9%)
scPharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-J. Luther King, Jr.(4.6%),Luther King Capital Management Corporation(4.5%)
scPharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director SCHAEFFER LEONARD D
scPharmaceuticals | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Officer Nokes Rachael
scPharmaceuticals | 4: Statement of changes in beneficial ownership of securities-10% Owner ORBIMED ADVISORS LLC
scPharmaceuticals | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-OrbiMed Advisors LLC(12.1%),OrbiMed Capital GP VI LLC(11.6%), etc.
scPharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Nokes Rachael
scPharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-J. Luther King, Jr.(6.4%),Luther King Capital Management Corporation(6.1%)
scPharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Khattar Jack A.
scPharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Hudson Frederick M.
scPharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Agger Mette Kirstine
scPharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director SCHAEFFER LEONARD D
scPharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Abraham William Tober
scPharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director VEITINGER KLAUS R DR
scPharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Baylor-Henry Minnie
scPharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Bonstein Sara
scPharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-J. Luther King, Jr.(5.3%),Luther King Capital Management Corporation(5.0%)
scPharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-Laurence W. Lytton(5.1%)